ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
Ernexa Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.98−0.11 (-5.26%)
Close on Oct 19, 2026
- Market cap
- $2.34M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 4, 2026 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Jun 12, 2025 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Oct 17, 2022 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| May 17, 2021(first seen in filings) | 6-for-1 | Earlier per-share figures divided by 6 |
| Mar 26, 2021 | 1-for-2 reverse | Earlier per-share figures multiplied by 2 |
| Aug 4, 2016(first seen in filings) | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Jun 17, 2016 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |